Point-of-care testing INR: an overview

Abstract Oral anticoagulant therapies with the anti-vitamin K drugs (AVK), warfarin, acenocoumarol and phenprocoumon, are employed in primary and secondary anti-thrombotic prophylaxis in patients with venous thromboembolism, atrial fibrillation and cardiac mechanical valves. However, a monitoring test such as the International Normalized Ratio (INR) is required. The periodic monitoring of this therapy entails discomfort for the patients. Telemedicine and telecare can provide significant aid in the management of this therapy allowing patients to perform the test at home or anywhere else with a portable device, i.e. point-of-care testing (POCT), and to send the result to a thrombosis (TC) via web. Patients can receive dose adjustment sent back by the TC. The effectiveness of this type of management is equal or superior to the traditional AVK monitoring in terms of hemorrhagic and thrombotic events. Analysis of the costs with a horizon of 10 years reveals that both self-testing and self-management are cost-effective. The aim of this overview is to describe the pros and cons of the use of POCT as an alternative in the monitoring of AVK. In particular, description of the POCT, decentralization, quality of the therapy, safety and costs will be examined.

[1]  G. Palareti,et al.  External quality assessment (EQA) for CoaguChek monitors , 2010, Thrombosis and Haemostasis.

[2]  N. G. Christensen,et al.  External quality assessment of prothrombin time: The split‐sample model compared with external quality assessment with commercial control material , 2006, Scandinavian journal of clinical and laboratory investigation.

[3]  M. Moia,et al.  Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK). , 2000, Haematologica.

[4]  M. Piras,et al.  Antiphospholipid syndrome patients: the performance of Coagucheck XS in the monitoring of Vitamin K-Antagonists. , 2012, Thrombosis Research.

[5]  D. Fitzmaurice,et al.  Self-monitoring and self-management of oral anticoagulation. , 2016, The Cochrane database of systematic reviews.

[6]  G. Müller‐Berghaus,et al.  State-of-the-Art Patient Self-Management for Control of Oral Anticoagulation , 1999, Seminars in thrombosis and hemostasis.

[7]  D. Fitzmaurice,et al.  Self-monitoring and self-management of oral anticoagulation. , 2010, Sao Paulo medical journal = Revista paulista de medicina.

[8]  R. Machovich.  Effect of calcium phosphate on thrombin and on its sensitivity to heparin and antithrombin-III. , 1976, Thrombosis research.

[9]  R. Perera,et al.  Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation: A Systematic Review , 2008, Circulation. Cardiovascular quality and outcomes.

[10]  T. Wilt,et al.  Meta-analysis: Effect of Patient Self-testing and Self-management of Long-Term Anticoagulation on Major Clinical Outcomes , 2011, Annals of Internal Medicine.

[11]  F. Rosendaal,et al.  Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. , 2003, Archives of internal medicine.

[12]  P. Mannucci,et al.  Are Capillary Whole Blood Coagulation Monitors Suitable for the Control of Oral Anticoagulant Treatment by the International Normalized Ratio? , 1993, Thrombosis and Haemostasis.

[13]  M. Gold.  Effect of Home Testing of International Normalized Ratio on Clinical Events , 2011 .

[14]  A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. , 2000, Thrombosis and haemostasis.

[15]  C. Ramsay,et al.  Is self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluation , 2015, BMJ Open.

[16]  Mark Crowther,et al.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[17]  S. Sandberg,et al.  External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe , 2011, Clinical chemistry and laboratory medicine.

[18]  T B Kirkwood,et al.  Calibration of Reference Thromboplastins and Standardisation of the Prothrombin Time Ratio , 1983, Thrombosis and Haemostasis.

[19]  D. Fitzmaurice,et al.  Cohort study of Anticoagulation Self-Monitoring (CASM): a prospective study of its effectiveness in the community , 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.

[20]  K. Cimon,et al.  Safety and effectiveness of point-of-care monitoring devices in patients on oral anticoagulant therapy: a meta-analysis , 2007, Open medicine : a peer-reviewed, independent, open-access journal.

[21]  Sebastian Schneeweiss,et al.  Comparative Efficacy and Safety of New Oral Anticoagulants in Patients With Atrial Fibrillation , 2012, Circulation. Cardiovascular quality and outcomes.

[22]  G. Palareti,et al.  Assessment of mental ability in elderly anticoagulated patients: its reduction is associated with a less satisfactory quality of treatment , 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[23]  J. Ansell,et al.  Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times. , 1989, Archives of internal medicine.

[24]  A. St John.  The Evidence to Support Point-of-Care Testing. , 2010, The Clinical biochemist. Reviews.

[25]  Kristin L. Bussey-Smith,et al.  Impact of a New Method of Warfarin Management on Patient Satisfaction, Time, and Cost , 2013, Pharmacotherapy.

[26]  S. Testa,et al.  Reorganisation of an anticoagulation clinic using a telemedicine system: description of the model and preliminary results , 2006, Internal and emergency medicine.

[27]  T. Larsen,et al.  Precision and accuracy of point‐of‐care testing coagulometers used for self‐testing and self‐management of oral anticoagulation therapy , 2012, Journal of thrombosis and haemostasis : JTH.

[28]  G. Lip,et al.  Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin , 2016, Stroke.

[29]  M. Moia,et al.  Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results , 2012, Journal of thrombosis and haemostasis : JTH.

[30]  F. Marongiu,et al.  Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful? , 2009, Thrombosis research.

[31]  F R Rosendaal,et al.  A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy , 1993, Thrombosis and Haemostasis.

[32]  D. Vaira.  Diagnosing small bowel malabsorption , 2014, Internal and Emergency Medicine.

[33]  S. Kitchen,et al.  Point-of-care International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of three different monitors , 2006, Thrombosis and Haemostasis.

[34]  F. Marongiu,et al.  Telemedicine can improve the quality of oral anticoagulation using portable devices and self-testing at home , 2013, Journal of telemedicine and telecare.

[35]  P. Fernlund,et al.  Vitamin K dependent modifications of glutamic acid residues in prothrombin. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Juan Carlos Souto,et al.  Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data , 2012, The Lancet.

[37]  D. Singer,et al.  Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 2016, Journal of the American Heart Association.